About GlycoSpot
GlycoSpot is a Healthcare company based in Frederiksberg (Denmark) founded in 2014 by Mads Hartvig Clausen and Frank Hansen. It operates as a high-throughput enzyme screening solutions are developed and provided. GlycoSpot has raised $3.58 million across 3 funding rounds. GlycoSpot was last valued at $6.92 million in June 2022. GlycoSpot offers products and services including MINI-LAB, The App, Enzyme Screening, and Test-Kits. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Glycobiology. Its legal entity is GlycoSpot ApS. Its competitors include GlyTech, Iceni Glycoscience, Echelon Biosciences, Avanti Polar Lipids and TFChem and 3 more; 2 of its 8 listed competitors have raised funding.
Company details
GlycoSpot was founded in 2014 in Frederiksberg, Denmark, within the biotechnology sector. Solutions for high-throughput enzyme screening are developed, focusing on dyed chromogenic polymer hydrogel substrates such as CPH-amylopectin, CPH-galactomannan, and CPH-β-glucan. Operations include standard 96-well CPH kits, Multi-CPH kits with multiple substrates per plate, and ICB substrate kits, supporting enzymatic activity assessments in research settings.
- Headquarters Frederiksberg, Denmark
- Founders Mads Hartvig Clausen, Frank Hansen
- Stage Minicorn
- SectorsHealthcare
- Website glycospot.dk
- Social LinkedIn X YouTube
- Legal Name Glycospot Aps
- Total Equity Funding$3.58M (USD)
in 3 rounds
- Latest Funding Round$344.2K (USD), Seed
Jun 2022
Products & Services of GlycoSpot
GlycoSpot offers a comprehensive portfolio of products and services, including MINI-LAB, The App, Enzyme Screening, and Test-Kits.
Handheld kit for enzyme analysis without specialized training.
Simplifies enzyme screening and R&D processes for users.
Application-specific kits for accurate enzyme activity checks.
All-inclusive sets for hassle-free enzyme testing in various fields.
Apps and channels of GlycoSpot
its YouTube channel GlycoSpot has 960 subscribers and 14 videos.
Videos from GlycoSpot
The most watched videos on GlycoSpot's YouTube channel, GlycoSpot (960 subscribers). Click a video to play it here.
More on GlycoSpot.
Funding Insights of GlycoSpot
GlycoSpot has successfully raised a total of $3.58M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $344.2 thousand completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.58M
- Total Rounds 3
- Last Round Seed β $344,201
- First Round $957,521
(May 2018)
All 3 funding rounds of GlycoSpot with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2022 | $344,201 | Seed | $6.92M | β | β |
| May 2020 | $2.27M | Seed | $6.64M | β | β |
| May 2018 | $957,521 | Seed | $β’β’β’β’β’ | β | β |
| Date | Valuation | Stage |
|---|---|---|
| Jun 2022 | $6.92M | β’β’β’β’β’β’β’β’ |
| May 2020 | $6.64M | β’β’β’β’β’β’β’β’ |
| May 2018 | $β’β’β’β’β’ | β’β’β’β’β’β’β’β’ |
Full valuation and stage history of GlycoSpot
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $6.92M (Jun 2022).
People of GlycoSpot
2 people are tracked at GlycoSpot (2 in leadership).
| Name | Role | Group |
|---|---|---|
Mads Hartvig Clausen | Founder | Leadership |
Frank Hansen | Founder | Leadership |
Complete people profiles for GlycoSpot
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of GlycoSpot
4 dated milestones of GlycoSpot across 8 years, from founding to its latest funding, stage changes and deals.
- Founded GlycoSpot is founded.
- Funding First funding round of $958K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Seed, of $344K.
Competitors of GlycoSpot
GlycoSpot has 8 listed competitors in our database, 2 of them funded. They include GlyTech, Iceni Glycoscience, Echelon Biosciences, Avanti Polar Lipids and TFChem, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| glytech-inc.com | 2012 | Kyoto, Japan | $9.14M | – | Human-type Asp-linked glycans are supplied for research applications. | |
| iceniglycoscience.com | 2014 | Norwich, United Kingdom | $1.77M | 16 | Glycoscience platform is provided for diagnostic and therapeutic applications. | |
| echelon-inc.com | 1997 | Salt Lake, United States | – | – | Reagents and assays for lipid biology research are manufactured. | |
| avantilipids.com | 1969 | Alabaster, United States | – | 134 | Phospholipids and lipids are manufactured for life science applications. | |
| tfchemistry.com | 2007 | Rouen, France | – | – | Fluoride chemistry is utilized to design glycomimetic drug compounds. | |
| addaxbio.com | 2017 | Turin, Italy | – | – | Developer of a non-toxic formalin alternative tissue fixative. This fixative provides comparable or superior results to formalin in histological, immunohistochemical, and molecular analyses, while eliminating the carcinogenic and toxic risks associated with formalin use. The product is protected by an international patent and is designed for use in histology laboratories, improving both patient care and worker safety. The company collaborates with various research institutions to advance the application of this technology in different fields. | |
| enzabiotech.com | 2012 | Lund, Sweden | – | – | Biobased nonionic surfactants are developed for various applications. | |
| prozyme.com | 1990 | Hayward, United States | – | – | Biochemical reagents and services for glycosciences are provided. |
Detailed competitors of GlycoSpot
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as GlycoSpot (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about GlycoSpot
GlycoSpot was founded in 2014 and raised its 1st funding round 4 years after it was founded.
GlycoSpot is headquartered in Frederiksberg, Denmark.
GlycoSpot is a funded company, having raised a total of $3.58M across 3 funding rounds to date. The company's 1st funding round was a Seed of $957.52K, raised on May 2018.
GlycoSpot was founded in 2014 in Frederiksberg, Denmark, within the biotechnology sector. Solutions for high-throughput enzyme screening are developed, focusing on dyed chromogenic polymer hydrogel substrates such as CPH-amylopectin, CPH-galactomannan, and CPH-Ξ²-glucan. Operations include standard 96-well CPH kits, Multi-CPH kits with multiple substrates per plate, and ICB substrate kits, supporting enzymatic activity assessments in research settings.
GlycoSpot's top competitors include GlyTech, Echelon Biosciences and Iceni Glycoscience.
GlycoSpot offers MINI-LAB, The App, Enzyme Screening, and Test-Kits.
The valuation of GlycoSpot is $6.92M as of Jun 2022.
GlycoSpot operates through Glycospot Aps.